1. Gastrodin ameliorates Concanavalin A-induced acute hepatitis via the IL6/JAK2/STAT3 pathway. (2nd November 2022) Authors: Zhou, Yingqun; Chen, Jiaojiao; Yao, Zhilu; Gu, Xuezhen Journal: Immunopharmacology and immunotoxicology Issue: Volume 44:Number 6(2022) Page Start: 925 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Isorhamnetin Inhibits Liver Fibrosis by Reducing Autophagy and Inhibiting Extracellular Matrix Formation via the TGF-β1/Smad3 and TGF-β1/p38 MAPK Pathways. (31st July 2019) Authors: Liu, Ning; Feng, Jiao; Lu, Xiya; Yao, Zhilu; Liu, Qing; Lv, Yang; Han, Yuru; Deng, Jingfan; Zhou, Yingqun Other Names: Petricevich Vera L. Academic Editor. Journal: Mediators of inflammation Issue: Volume 2019(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. MiR-22-3p/PGC1β Suppresses Breast Cancer Cell Tumorigenesis via PPARγ. (13th March 2021) Authors: Wang, Xuehui; Yao, Zhilu; Fang, Lin Other Names: Li Sainan Academic Editor. Journal: PPAR research Issue: Volume 2021(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗